1. Home
  2. RGNX vs ANPA Comparison

RGNX vs ANPA Comparison

Compare RGNX & ANPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • ANPA
  • Stock Information
  • Founded
  • RGNX 2008
  • ANPA 2016
  • Country
  • RGNX United States
  • ANPA Hong Kong
  • Employees
  • RGNX N/A
  • ANPA N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • ANPA
  • Sector
  • RGNX Health Care
  • ANPA
  • Exchange
  • RGNX Nasdaq
  • ANPA Nasdaq
  • Market Cap
  • RGNX 445.5M
  • ANPA 465.1M
  • IPO Year
  • RGNX 2015
  • ANPA 2025
  • Fundamental
  • Price
  • RGNX $8.82
  • ANPA $48.00
  • Analyst Decision
  • RGNX Strong Buy
  • ANPA
  • Analyst Count
  • RGNX 8
  • ANPA 0
  • Target Price
  • RGNX $28.50
  • ANPA N/A
  • AVG Volume (30 Days)
  • RGNX 687.5K
  • ANPA 43.0K
  • Earning Date
  • RGNX 08-07-2025
  • ANPA 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • ANPA N/A
  • EPS Growth
  • RGNX N/A
  • ANPA 1.75
  • EPS
  • RGNX N/A
  • ANPA 0.07
  • Revenue
  • RGNX $155,782,000.00
  • ANPA $5,884,401.00
  • Revenue This Year
  • RGNX $327.08
  • ANPA N/A
  • Revenue Next Year
  • RGNX N/A
  • ANPA N/A
  • P/E Ratio
  • RGNX N/A
  • ANPA $719.17
  • Revenue Growth
  • RGNX 74.95
  • ANPA N/A
  • 52 Week Low
  • RGNX $5.04
  • ANPA $2.80
  • 52 Week High
  • RGNX $13.48
  • ANPA $54.75
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 53.29
  • ANPA N/A
  • Support Level
  • RGNX $7.83
  • ANPA N/A
  • Resistance Level
  • RGNX $9.24
  • ANPA N/A
  • Average True Range (ATR)
  • RGNX 0.51
  • ANPA 0.00
  • MACD
  • RGNX 0.08
  • ANPA 0.00
  • Stochastic Oscillator
  • RGNX 77.37
  • ANPA 0.00

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.

Share on Social Networks: